# NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers

> **NCT04905342** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 58 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** NVP-1805
- **DRUG:** NVP-1805-R1and NVP-1805-R2

## Key facts

- **NCT ID:** NCT04905342
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-14
- **Primary completion:** 2021-12-20
- **Final completion:** 2022-01-07
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2022-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04905342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04905342, "NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04905342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*